DNA X, Inc. (SONM) Fair Value 2026

SONM · Capital Markets ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.1 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (46/100)

Quick Summary — As of 2026-08-28, DNA X, Inc. (SONM) trades at $3.46. QOC: 3.1/10. Value Trap Risk: 46/100 (WARN). 1/13 models active.

Key Facts

Ticker
SONM
Price
$3.46
Quality Score
3.1/10
Value Trap Risk
46/100
Models Active
1/13
Last Updated
Strength: Dynamic NAV suggests +24.9% upside with 49% confidence
Risk: Value Trap score of 46 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give SONM?

1 Intrinsic Value Models vs. Current Price ($3.46)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $4.32 +24.9%

All Models Active

All 1 models are displayed above.

What Is DNA X, Inc. (SONM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, DNA X, Inc. is potentially undervalued at its current price of $3.46. Based on our 13-model framework, DNA X, Inc.'s intrinsic value is estimated at a median fair value of $4.32 — representing +24.9% implied upside — with 1 out of 1 active models confirming this thesis.

What Do the Models Say About SONM?

1 of 13 models are currently active for SONM. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does SONM Rank in Capital Markets?

Among 103 Capital Markets stocks, SONM ranks #93 by Quality of Company score. CirclFi's QOC score of 3.1/10 evaluates 32 fundamental signals. A score of 3.1 signals below-average fundamentals.

See all Most Undervalued Capital Markets Stocks →

As a lending environment, DNA X, Inc. operates in a sector where deposit growth is a critical driver of valuation. Investors evaluating SONM should weigh these sector-specific dynamics alongside our model-derived fair values.

Is SONM a Value Trap?

CirclFi's Value Trap algorithm assigns SONM a score of 46/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for DNA X, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, DNA X, Inc.'s fundamental quality profile registers 3.1/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SONM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SONM's 1 active models, average confidence is 49%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy DNA X, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Capital Markets Stocks Should You Also Analyze?

11 related Capital Markets stocks with 13-model coverage

USDEStablecoinX Inc.QOC 3.3TIGRUP Fintech Holding LimitedQOC 3.0BTGOBitGo Holdings, Inc.QOC 3.5WTFWaton Financial LimitedQOC 2.9MGTIMGT Capital Investments, Inc.QOC 3.5AUREAurelion Inc.QOC 2.7VIRTVirtu Financial, Inc.QOC 7.9PURRHyperliquid Strategies Inc.QOC 6.2AUCATIF Holdings LimitedQOC 5.2FUTUFutu Holdings LimitedQOC 9.8HOODRobinhood Markets, Inc.QOC 9.7

Read investment analysis: USDE · TIGR · BTGO · WTF · MGTI · AURE · VIRT · PURR · AUC · FUTU · HOOD

Which Other Stocks Have a Similar Quality Score to SONM?

7 companies across all industries closest to SONM’s Quality of Company score of 3.1/10.

LOTLotus Technology Inc.QOC 3.1MGAMagna International Inc.QOC 3.1ADTIAdapti, Inc.QOC 3.1ELREYinfu Gold CorporationQOC 3.1GAUGaliano Gold Inc.QOC 3.1GCANTrafalgar International, Inc.QOC 3.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LOT · MGA · ADTI · ELRE · GAU · GCAN · NVDA

Where Does SONM Sit in CirclFi's Capital Markets Rankings?

SONM is ranked against every other Capital Markets stock CirclFi covers in each of these screens.

See all Capital Markets stocks ranked →

What Else Do Investors Ask About DNA X, Inc.’s Valuation?

What is DNA X, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for DNA X, Inc. (SONM). The Quality of Company score is 3.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SONM overvalued or undervalued right now?

At $3.46, 1 of 1 active models suggest SONM may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits DNA X, Inc.'s business model in Capital Markets.

What does a Quality of Company score of 3.1 mean for SONM?

DNA X, Inc.'s QOC of 3.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on SONM?

CirclFi analyzes SONM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is SONM a value trap in 2026?

DNA X, Inc.'s Value Trap score is 46/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns DNA X, Inc. (SONM) a Quality of Company score of 3.1/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SONM/ · Methodology
Primary sources for this SONM valuation
  • Financial statements: DNA X, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001178697) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SONM as of ; valuations recomputed .